Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma.

Thyroid : official journal of the American Thyroid Association - 1 May 2024

Jiang Yu-Jia, Xia Yun, Hu Yi-Xuan, Han Zhuo-Jun, Guo An-Yuan, Huang Tao

Abstract excerpt

Background: Familial non-medullary thyroid carcinoma (FNMTC) is a genetically predisposed disease with unclear genetic mechanisms. This makes research on susceptibility genes important for the diagnosis and treatment options. Methods: This study included a five-member family affected by papillary thyroid carcinoma. The candidate genes were identified through whole-exome sequencing and Sanger sequencing in family...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Exome Sequencing

Share to p21-Activated Kinases

Share to Pedigree

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 38411500
DOI: 10.1089/thy.2023.0564

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma.PMID 38411500Read ↗

Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.Semantic proximity Read ↗

Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.Semantic proximity Read ↗

Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling PathwaysSemantic proximity Read ↗

Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling PathwaysSemantic proximity Read ↗

Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)Semantic proximity Read ↗

Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer.Semantic proximity Read ↗

Does a common genetic event exist for familial thyroid cancer? Results from a large family with FNMTCSemantic proximity Read ↗

Whole-Exome Sequencing Reveals Hippo Pathway Mutations as a Hallmark of Aggressive PTMC in Young MalesSemantic proximity Read ↗

Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.Semantic proximity Read ↗

MCM2 germline variants predispose to familial papillary thyroid carcinoma due to genomic instability caused by MCM complex disruption.Semantic proximity Read ↗

Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred.Semantic proximity Read ↗

p21-Activated Kinases in Thyroid CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.